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Abstract
Streptococcus equi ssp. zooepidemicus (S. zooepidemicus, S.z) is one of the common pathogens that can cause septicemia,
meningitis, and mammitis in domesticated species. M-like protein (SzP) is an important virulence factor of S. zooepidemicus
and contributes to bacterial infection and antiphagocytosis. The interaction between SzP of S. zooepidemicus and porcine
thioredoxin (TRX) was identified by the yeast two-hybrid and further confirmed by co-immunoprecipitation. SzP interacted
with both reduced and the oxidized forms of TRX without inhibiting TRX activity. Membrane anchored SzP was able to
recruit TRX to the surface, which would facilitate the antiphagocytosis of the bacteria. Further experiments revealed that
TRX regulated the alternative complement pathway by inhibiting C3 convertase activity and associating with factor H (FH).
TRX alone inhibited C3 cleavage and C3a production, and the inhibitory effect was additive when FH was also present. TRX
inhibited C3 deposition on the bacterial surface when it was recruited by SzP. These new findings indicated that S.
zooepidemicus used SzP to recruit TRX and regulated the alternative complement pathways to evade the host immune
phagocytosis.
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Introduction
Streptococcusequissp.zooepidemicus(S.zooepidemicus,S.z),amemberof
the Lancifield’s group C, is an opportunistic pathogen that could
infect a wide variety of non-human species, including important
domesticated cattle such as horses, cows, swine, sheep, and dogs. In
China, S. zooepidemicus is the major cause of diseases in swine.
Occasionally, it can infect humans via zoonotic transmission from
the infected animals and cause invasive infections in humans such as
septicemia and meningitis. [1,2]. Pathogenic microorganisms in a
nonimmunehostmustevade fromtheinnateimmunesystem before
the infection can be established [3]. Many pathogens have unique
surface structures that can interfere with the phagocytosis by the
neutrophils [4]. The hyaluronic acid capsules expressed by many
strains can also hinder the phagocytosis process [5]. M protein is an
important virulence factor of group A streptococci: this fibrillar,
surface-exposed protein deters opsonization of the organism using
the alternate complement pathway [6,7]. Previous studies have
demonstrated that S. zooepidemicus carry antigens with antiphagocy-
tic characteristics similar to the M proteins expressed from
Lancefield group A and G streptococci; hence it was named M-like
protein (SzP) [8]. SzP is a cell surface-anchored protein that confers
phagocytosis resistance [9]. SzP-knockout strains had 1000-fold
decrease in LD50 compared to the wild type [10]. However, the
molecular mechanism by which SzP protects S. zooepidemicus from
phagocytosis is poorly understood.
Thioredoxin (TRX) is a small multifunctional protein with a
redox-active dithiol/disulfide in the conserved active site. The
functions of TRX are to reduce protein disulfide bonds and to
scavenge hydrogen peroxide together with peroxiredoxins [11]. It
was originally identified as a cytokine-like factor in virus-
transformed cells [12]. TRX is localized in the cytosol and on
the cell surface. The release of TRX in various cells types can be
triggered by different extracellular stimuli [13]. Many pathogenic
bacteria can evade the complement-mediated host defense by
recruiting factor H (FH) to the bacterial surfaces. [14–16]. M and
M-like proteins show affinity for FH, their interaction is proposed
as the mechanism by which M and M-like proteins exert their
antiphagocytic effects [17,18]. The C3 convertase activity analysis
found that TRX could inhibit the conversion of C3 to C3a and
C3b. This suggested that TRX could have a similar function with
FH, which was consistent with previous findings [19].
Our studies were focused on the molecular mechanism(s) by
which SzP protects S. zooepidemicus from phagocytosis. We identified
the SzP/TRX interaction and found that the activity of TRX was
not inhibited by this interaction. We also found that TRX could
facilitate the antiphagocytic process when it was recruited by SzP
anchored on the surface of S. zooepidemicus. Further experiments
showed that TRX regulated the alternative complement pathway
via C3 convertase inhibition and FH association. TRX alone could
inhibit C3 cleavage and C3a production, and the inhibitory effect
wasadditivewith FH.TRXwas able toinhibit C3deposition onthe
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our knowledge, this was the first reported identification of SzP/
TRXinteraction.Itmediated resistancetothephagocyticactivityof
macrophages. Our findings could contribute to the general
understanding on how SzP confers phagocytosis resistance.
Results
S. zooepidemicus M-like protein (SzP) interacts with
Thioredoxin
The coding region of ATCC35246 SzP in S. zooepidemicus was
screened against a porcine pulmonary alveolar macrophage (PAM)
cDNA library using the Split-ubiquitin yeast two-hybrid (Y2H)
technique. In the Y2H screen, 28 proteins were identified to have
a potential interaction with the SzP protein in the yeast cells
growing on Trp
2 Ade
2 His
2 Leu
2 80 mM aminotriazole media
(Sigma). Thioredoxin (TRX, GenBank No. NM_214313.1) was
repetitively identified 13 times (Table 1). The fusion plasmids
carrying these 28 proteins were isolated after the first round of the
screen and retested in fresh yeast cells containing pDHB1-SzP.
Only 12 potential SzP interacting proteins were identified in the
retest and they were pursued further. Figure 1A showed the
interaction between SzP and TRX with appropriate controls. A
total of 12 candidate SzP interacting proteins were identified from
the retest and their putative functions were listed in Table 1.
The result obtained with the two-hybridsystem wasconfirmed by
Co-IP through two independent detection approaches. A ProLabel
tag (an enzyme capable of producing a strong chemiluminescent
signal via catalyzing its substrate) was genetically integrated at the
N-terminal of each of these 12 candidate proteins using the vector
pProLabel-C. pProLabel-C or pProLabel-C fused with the
candidate protein were then transfected into HEK 293 cells with
plasmid pAcGFP1-C, expressing GFP alone, or with plasmid
pAcGFP1-SzP, a derivative of pAcGFP1-C coding for a GFP-SzP
fusion protein. For the chemiluminescent detection approach,
protein G plus/A agarose beads and anti-GFP monoclonal
antibodies were incubated with the transfected HEK293 lysate
and the luminescence level of the substrate-ProLabel reaction was
measured. As seen in Figure 1B, the luminescence signal was only
detected when SzP and TRX were both present, while GFP or
ProLabel-tag alone was unable to bind with TRX or SzP. TRX was
the only one of these 12 candidate proteins that co-immunoprecip-
itated with SzP in vitro. In addition, Western-Blot detection
approach was performed. Protein G plus/A agarose beads and
anti-TRX antibodies were incubated with the transfected HEK293
lysate and GFP-SzP was detected with the anti-GFP monoclonal
antibodies. Figure 1C was consistent with these results. Altogether,
we identified the interaction of SzP/TRX for the first time.
SzP interacts with oxidized and reduced TRX in vitro
We investigated if the SzP/TRX interaction was dependent on
oxidized or reduced form of TRX. For this purpose, TRX bound
protein G beads were coated with anti-TRX polyclonal antibodies
and treated with H2O2 before the in vitro binding assay. We found
a clear difference of migration in polyacrylamide gels between the
H2O2-treated and the DTT-treated TRX (Figure 2A). This result
suggested the efficiency of the oxidative modification by H2O2,
which was consistent with previous findings [20]. However, the
oxidative treatment did not noticeably hinder the SzP/TRX
interaction. The interaction was still present with reduced TRX in
the DTT treated samples (Fig. 2B).
SzP and TRX interaction does not inhibit TRX activity
The conserved active site of TRX has two cysteines that are
essential forits redoxactivity. Previous reportshowedthat the active
site was where some TRX interaction partners bind [21]. We
decided to investigate if this site was also necessary for the bindingof
SzP. TRX-pPR3-N and Mut-Trx-pPR3-N (C32S/C35S), a Cys32
and Cys35 mutant, were transformed into the yeast strain NMY51
containing a bait plasmid SzP-pDHB. The transformed yeast
colonies grew on Trp
2 Ade
2 His
2 Leu
2 80 mM aminotriazole
selective media. Both the wild-type and the mutant TRX were able
to interact with SzP, suggesting that the integrity of the active site
was not necessary for this interaction (Fig. 1D).
Table 1. Candidate SzP interacting proteins and their putative functions.
Interactor Number of hits Protein function
Thioredoxin 13 In our article
Glia maturation factor gamma-like 5 Maybe involved in glial differentiation, neural regeneration, and inhibition
of tumor cell proliferation
Mitochondrial import receptor subunit TOM6 homolog 3 Modulate the assembly and dissociation of the multisubunit preprotein
translocase (Tom) machinery of the mitochondrial outer membrane
Selenoprotein K 3 Boosting the immune function in host defence and inflammatory diseases
Protein Sec61 subunit beta-like 2 Proteins enter the ER by the Sec61 translocon, a proteinaceous channel
composed of three subunits, alpha, beta and gamma.
BCL2/adenovirus E1B 19 kDa interacting protein 3-like 1 Cause cell death by targeting mitochondria
Syntaxin 8 1 Involved in vesicular trafficking and docking
Transmembrane protein CD9 1 Member of the tetraspan transmembrane protein family, which facilitates,
the infection of tissue culture cells with CDV
Guanine nucleotide binding protein (G protein), gamma 11 1 G proteins are heterotrimers consisting of a, b, c subunits, involved in
signal transduction
TRAF3-interacting JNK-activating modulator-like 1 An adapter molecule that specifically regulates TRAF3-mediated JNK
activation
Mast cell-expressed membrane protein 1-like 1 Homologous to human granule membrane protein 17
Clone:AMP010010B04, expressed in alveolar macrophage 1 Unknown
doi:10.1371/journal.pone.0032099.t001
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TRX activity, we used an in vitro insulin reduction assay to
measure the reducing activity of TRX. Our results showed that
high concentration of SzP did not inhibit TRX activity (Fig. 2C).
The SzP/TRX interaction did not inhibit TRX activity and
rendered TRX more prone to the complement pathway regulation
and other biological functions.
S. zooepidemicus recruits TRX to the surface and
facilitates antiphagocytosis
We further determined that TRX interacted with SzP of viable
S. zooepidemicus. S. zooepidemicus wild strain and the SzP-knockout
strain were both incubated with TRX. PBS was used as a negative
control. After suitable treatment, all 3 samples were analyzed using
flow cytometry. We found that the S. zooepidemicus wild type, but
not the SzP-knockout strain, was able to recruit TRX to its surface
(Fig. 3). This suggested that the surface anchored SzP was
important for TRX recruitment.
The recruitment of TRX to the cell surface of S. zooepidemicus’s
suggested that this interaction could enhance the bacterial
adaptation in hosts, thus contribute to the antiphagocytosis of S.
zooepidemicus. We investigated this issue by assessing the effect of the
SzP/TRX interaction on the phagocytosis in vitro. We employed
RNA interference to knock down endogenous TRX expression in
the macrophages. Using RT-PCR, we found that the level of TRX
mRNA was reduced to less than 15% in macrophages treated with
Figure 1. The interaction between SzP and TRX. A: The split-ubiquitin yeast two hybrid assay. SzP was cloned in frame into the yeast expression
vector (pDHB1), fused at its N-terminus to a small membrane anchor (the yeast ER protein Ost4) and at its C-terminus to a reporter cassette
composed of the C-terminal half of ubiquitin (Cub) and a transcription factor (LexA-VP16). The recombinant TRX-pPR3-N (fusion to the mutated N-
terminal half of ubiquitin) and SzP-pDHB1 were co-transformed into the NMY51 yeast strain. The co-transformed cells were selected on Trp-/Ade-/
His-/Leu- 80 mM Aminotriazole dropout plates. The control+ represented co-transformation of pDSL-Delta-p53 and pDHB1-largeT (Dualsystems
Biotech, Switzerland). Tubes showed the results of Liquid b-galactosidase assay. B: Luminescence value of the substrate corresponding to the
pProLabel tag fused to TRX. Histogram showed max luminescence value through 1 h monitoring (n=3, mean6SD, ** indicates that a value was
significantly different (p,0.01)from the control- group). C: SzP was immunoprecipitated from HEK293 cells expressing TRX. HEK293 lysates were
immunoprecipitated with rabbit polyclonal antibodies against TRX. The immunoprecipitates were subjected to the western blotting analysis with
GFP monoclonal antibodies against GFP -SzP. D: pDHB1-SzP and pPR3-N-mut-TRX were co-transformed into the yeast strain NMY51. SzP interacted
with mutant TRX, which had mutations Cys
32 and Cys
35 to Ser (C32S/C35S) in its active site. Tubes showed the results of Liquid b-galactosidase assay.
doi:10.1371/journal.pone.0032099.g001
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significant decrease in TRX protein level in RNAi treated cells
then the nt-RNAi control cells (Fig. 4B, top panel). The level of b-
actin in macrophages was used as an internal control (Fig. 4B,
bottom panel).
S. zooepidemicus wild strain and SzP-knockout strain were tested
in an in vitro phagocytosis assay Briefly, mouse macrophages with
or without mouse serum were treated with the wild strain and
TRXi strain cells. The ingestion of SzP-knockout strain in the wild
and TRXi Raw264.7 cells suggested that the phagocytosis of the
macrophages was not inhibited by the TRX interference. Serum
was used as a source of the complement system. It had an
opsonophagocytosis effect which allowed the macrophages to
ingest bacteria more efficiently. Our result suggested that TRX
could hinder the opsonophagocytosis process, as S. zooepidemicus
containing surface TRX was less ingested by macrophages than
the SzP knock-out strain or the non-TRX treated S. zooepidemicus.
However, the phagocytosis was not affected by TRX in the
absence of the serum. SzP facilitated S. zooepidemicus to avoid
phagocytosis with or without the serum. All these results indicated
that TRX could hinder phagocytosis when it was recruited by SzP
on the bacterial surface in the presence of the serum. On the other
hand, SzP was able to elicit antiphagocytosis responses through
another mechanism in the absence of the serum (Fig. 5).
The complement pathway regulation
We used the immunoblotting analysis to demonstrate that FH
interacted with SzP, TRX and SzP/TRX complex. Previous
report found that TRX interacted strongly with FH [19]. We
found that SzP of S. zooepidemicus had affinity with FH as well. We
also found that the SzP/TRX complex, visualized by the band
above SzP and TRX, was able to bind with FH (Fig. 6A).
The effect of TRX, FH and SzP on the activity of C3 convertase
in the alternative complement pathway was determined using the
fluid phase assay. Next, we examined the effect of TRX on FH, a
major regulator of the alternative complement pathway and an
Figure 2. Oxidized and reduced forms of TRX can interact with SzP. A: TRX bound to protein G beads was treated with either 1 mM H2O2 or
100 mM DTT for 15 min at room temperature. The proteins were separated by native PAGE and visualized by the western blot analysis for His-tag
fused TRX. B: Oxidized and reduced forms of TRX were able to interact with SzP. His-TRX bound to protein G beads were incubated with Nonidet P-40
buffer or with buffer supplemented with 1 mM H2O2 for 15 min at room temperature. After extensive washing in the same buffer, the proteins were
submitted to the binding assay. As a control to revert oxidation, a part of the H2O2-treated fusion protein was incubated with buffer containing
100 mM DTT for 15 min prior to SzP incubation. C: SzP did not inhibit TRX activity. The insulin disulfide reduction assay was performed in the lysates
obtained from confluent cultures described under ‘‘Materials and Methods.’’ The activity of TRX bound to SzP in vitro: TRX activity was detected after
incubating 10 mg TRX with 100 mg/ml or 500 mg/ml SzP at 37uC for 2 h. Control samples were treated with PBS. (n=3, mean6SD).
doi:10.1371/journal.pone.0032099.g002
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phase technique, the production of C3a from C3 conversion was
detected by adding factor B and factor D (Fig. 6B). We found that
TRX alone inhibited C3 cleavage. Furthermore, we found that the
inhibitory effect was additive with FH, as 5 mg TRX and 5 mgF H
together had a stronger inhibition on the activity of C3 convertase
than 10 mg TRX or 10 mg FH alone. SzP alone did not show any
effect on C3 cleavage. These results indicated that SzP could
recruit TRX as a regulator of the alternative complement pathway
and the regulation of TRX could also be distinct from the
regulation of FH.
Phagocytes can recognize foreign particles most efficiently after
opsonization with serum-derived opsonins such as IgG and C3b or
inactive C3b. Studies using C3 antibodies (anti-C3) showed that
TRX and FH both prevented C3b deposition on the S.
zooepidemicus wild strain (Fig. 6C, 6D). We detected more C3b
deposition on the cell surface of SzP-knockout strain compared to
the S. zooepidemicus wild strain after treatment with TRX and FH.
Immunoblotting with C3 specific antiserum revealed that the level
of surface localized C3b and iC3b, the major derivatives of C3,
was reduced after TRX or FH treatment in the presence of SzP.
The antiphagocytic effectiveness of the TRX was dose-dependent,
but when bacteria was saturated by TRX, the antiphagocytosis
stopped increasing. (Fig. 6E)
Discussion
There are generally cross-talks between bacteria and the host
immune system. S. zooepidemicus has developed a multitude of
strategies to evade host defenses by interfering many aspects of the
immune system. Such interference can normally lead to the down-
regulation or inhibition of the inflammatory responses. Previous
studies have indicated that SzP in S. zooepidemicus shares similar
antiphagocytic characteristics with the M proteins in the
Lancefield groups A and G streptococci [22]. SzP of S.
zooepidemicus is a 40.1-kD surface-anchored protein that elicits
serum opsonic and protective responses in mice and horses [9].
We cloned SzP gene of S. zooepidemicus ATCC35246 and
investigated the mechanism by which they conferred antiphago-
cytic effects against the host immune responses.
Figure 3. Recruitment of TRX to the surface of viable S. zooepidemicus. Flow cytometry results showed that TRX could bind to the surface SzP
of S. zooepidemicus.A :S. zooepidemicus wild strain incubated with PBS (negative control); B: SzP-knockout strain incubated with TRX; C: S.
zooepidemicus wild strain incubated with TRX. The SzP of S. zooepidemicus interacted with TRX and recruited TRX to the bacterial surface.
doi:10.1371/journal.pone.0032099.g003
Figure 4. TRX knockdown. A: The relative level of TRX mRNA was detected by RT-PCR. b-actin was used as the reference control. The mRNA level
of control was considered as 100%. The relative level of TRX mRNA was calculated using equation 2
2DDCT (n=3, mean6SD, the symbols, * and #,
indicate that a value differed significantly (p,0.05) from the control and nt-TRX RNAi treated groups, respectively.); B: Reduction in TRX protein levels
was confirmed by the western blot analysis in Raw264.7 cell. Lane 1 and 3 were nt-TRX RNAi plasmid treated cell lysis, lane 2 and 4 were TRX RNAi
plasmid treated cell lysis. All samples were extracted at 24 h after transfection.
doi:10.1371/journal.pone.0032099.g004
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classical yeast two-hybrid system was not successful. Classical Y2H
requires both proteins to interact in the nucleus and the nuclear
environment may cause certain proteins to fold improperly and
thus abolish their interactions with other proteins [23]. Next, we
used the split-ubiquitin yeast two-hybrid system to detect SzP
interaction partners. This system does not require protein
interactions to occur in the nucleus and is therefore ideal for
cytosolic proteins as well as membrane proteins. The C-terminal of
SzP is anchored to the membrane while the rest of the protein is
highly hydrophilic. We conjectured that the SzP/TRX interaction
occurred at the cytosolic side of the plasma membrane.
The current study identified the interaction between SzP and
TRX. We further provided three lines of evidence to verify that
SzP was associated with TRX; (i) An interaction between SzP and
TRX was screened and confirmed in the split-ubiquitin yeast two-
hybrid system. (ii) SzP and TRX were co-immunoprecipitated
from pAcGFP1-SzP and pProLabel-TRX transfected HEK293
cells, and the result was detected with ProLabel-tag enzyme
activity and confirmed with western-blot. (iii) FH was able to bind
with SzP and TRX, as well as the SzP/TRX complex. This
suggested that the binding of SzP to TRX was biologically
relevant.
TRX plays a variety of redox-related roles that are conserved
from E. coli to humans. It is a small, ubiquitous, multifunctional
protein that contains a redox-active disulfide/dithiol within its
active site, -Cys-Gly-Pro-Cys- [20]. TRX mutants with Cys32/
Cys35 to Ser mutations were still able to interact with SzP
(Fig. 1D). Furthermore, both oxidized and reduced forms of TRX
were able to interact with SzP (Fig. 2B). This suggested that the
redox active site was not the site of SzP/TRX interaction. It was
found that oxidization leads to TRX dimerization through a
disulfide bond between Cys73 in both monomers [24,25].
Therefore, the residues necessary for SzP interaction were not
hindered in the dimeric form of TRX. It was interesting to note
that the activity of TRX was not inhibited by SzP in vitro. These
results could explain why SzP/TRX interaction did not inhibit
TRX activity.
To better understand how surface protein SzP could contribute
to the pathogenecity of S. zooepidemicus, we investigated the
interaction of S. zooepidemicus with Raw264.7 cells, using the wild
strain ATCC35246 (which is virulent to mice) and SzP-knockout
strain attenuated in virulence. We employed flow cytometry to
detect the recruitment of TRX to the surface of viable S.
zooepidemicus. This recruitment was mediated by SzP, since SzP-
knockout strain was unable to recruit TRX to the surface. We also
found that both the S. zooepidemicus wild type and the SzP-knockout
strain were efficiently phagocytized by macrophages when TRX
was absent, though the wild strain was harder to be ingested than
the SzP-knockout strain. We believed that there should be another
mechanism of SzP to elicit antiphagocytosis responses in S.
zooepidemicus. The current work provided evidence that the S.
zooepidemicus wild strain could avoid being phagocytized much
more effectively, whereas the mutant strains were rapidly ingested
by Raw264.7 cells even in the presence of TRX. All these results
were obtained in the presence of the serum. However, TRX could
not facilitate antiphagocytosis responses in the absence of the
serum, it was only related to SzP. These results indicated the
expression of SzP allowed the bacteria to recruit TRX, which had
effects on the complement pathway. Therefore, the SzP/TRX
interaction facilitated the antiphgocytic response of the S.
zooepidemicus
Previous report found that the wild-type S. pyogenes expressing M
protein and/or M-like proteins on the cell surface could survive
inside the neutrophils [18]. S. pyogenes mutant strains that lacked
either M protein and/or M-like proteins were rapidly killed. M
and M-like proteins display affinity for several human plasma
proteins such as IgG [26], C4 BP [27], fibrinogen [28] and FH
[29]. It may be possible that these interactions could interfere with
normal host immune mechanisms, including phagocytosis. We
believed that SzP in S. zooepidemicus elicit antiphagocytosis through
its interaction with TRX.
FH can inhibit the conversion of C3 to C3a and C3b and
inactivate C3b. It is recognized as the main regulator of C3
convertase. Many pathogenic organisms evade phagocytosis by
coating their surface with the host FH [30]. We asked if S.
Figure 5. The SzP/TRX interaction facilitated S. zooepidemicus to avoid being phagocytized. The phagocytosis percentage of Raw264.7
wild strain and TRXi strain did not differ significantly. The S. zooepidemicus SzP-knockout strain were phagocytized effectually. In the presence of the
serum, the antiphagocytosis of S. zooepidemicus was more pronounced with the SzP/TRX interaction, as there was significantly more macrophage
containing ingested S. zooepidemicus in TRXi Raw264.7 cells than the wild type Raw264.7 cells. Thus, the SzP/TRX interaction reduced the
phagocytosis of S. zooepidemicus by the macrophages in the host immune system. The phagocytosis percentage of the TRX pretreated S.
zooepidemicus wild strain was significantly lower than the SzP-knockout strain in the TRXi Raw264.7 cells. In the absence of the serum, the
phagocytosis of the macrophages was independent of TRX, and only SzP was able affect phagocytosis (n=3, mean6SD, ** p,0.01).
doi:10.1371/journal.pone.0032099.g005
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32099Figure 6. SzP/TRX interaction contributed to the FH recruitment and reduced the C3 deposition on the bacterial surface, beneficial
for S. zooepidemicus to evade phagocytosis of the host immune system. A: The binding of FH to SzP (lane 1), TRX (lane 2) and the SzP/TRX
complex (Lane 3) was demonstrated by using polyclonal goat antiserum to FH in an immunoblot analysis. B: TRX inhibited C3 convertase activity in
the fluid phase. Fluid phase alternative pathway C3 convertase was generated by the addition of purified C3, C3i, factor B, and 0.1 M MgCl2.1 0mgo f
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SzP/TRX interaction. Our results showed that SzP, TRX and
SzP/TRX complex were able to bind with FH. This suggested
that the SzP/TRX interaction did not prohibit S. zooepidemicus to
recruit FH on its surface. We reasoned that although SzP itself
could recruit FH to the cell surface, SzP/TRX interaction was still
important because TRX could act as a regulator of the alternative
complement pathway not only in association with FH but also on
its own. TRX acted additively to FH in the alternative
complement pathway. The increased level of the capsules may
enhance phagocytosis resistance, but could also reduce adhesion to
the mucosal surface [31,32]. has less hyaluronic acid than S. equi.
Therefore, S. zooepidemicus has stronger adhesiveness but lower
level of capsules, which rendered it more susceptible to
phagocytosis [33]. Having an effective antiphagocytosis mecha-
nism is therefore essential to S. zooepidemicus. Recruiting FH via SzP
and TRX to its cell surface would certainly contribute to
phagocytosis evasion. When FH was not abundant, S. zooepidemicus
could use TRX as succedaneum of FH. C3 deposition experiments
showed that TRX and FH both prevented deposition of C3b on S.
zooepidemicus, which was pretreated with both TRX and FH limited
deposition of opsonic C3b on the bacterial surface. This indicated
that the SzP/TRX interaction contributed to the antiphagocytosis
response in S. zooepidemicus via the inhibition of the C3b deposition.
In conclusion, the SzP/TRX interaction was a novel anti-
phagocytic mechanism of S. zooepidemicus. The SzP/TRX
interaction did not influence the TRX activity and function. It
also contributed to the FH recruitment and reduced the C3
deposition on the bacterial surface, allowing S. zooepidemicus to be
more evasive to the alternative complement pathways. These
mechanisms were very beneficial for S. zooepidemicus to evade
phagocytosis of the host immune system. Additional studies of this
interaction will undoubtedly help us to understand better how SzP
is involved in the antiphagocytosis mechanisms.
Materials and Methods
Ethics
Porcine PAM was obtained with consent from one healthy pig
under the ethical approval granted by the Nanjing Agricultural
University Veterinary College. The protocol was approved by the
Science and Technology Agency of Jiangsu Province. The
approval ID is SYXK (SU) 2010-0005. All efforts were made to
minimize animal’s suffering.
Cell culture, bacterial strains and transfection conditions
Raw264.7 cells (ATCC) and HEK 293 cells (ATCC) were
maintained in the Dulbecco’s modified Eagle medium (DMEM)
high glucose (Gibco, Invitrogen Corp., Carlsbad, CA) supple-
mented with 10% fetal bovine serum (FBS). Cells were used from
passages 5–20.
The S. Zooepidemicus wild type strain ATCC35246 and the S.
zooepidemicus SzP-knockout strain was constructed by our lab [10].
Escherichia coli strains DH5a, DH10B and BL21, Saccharomyces
cerevisiae strain NMY51 (MATa his3D200 trp1-901 leu2-3,112
ade2 LYS2::(lexAop)4-HIS3 ura3::(lexAop)8-lacZ ade2::(lexAop)8-
ADE2 GAL4) were used in this study. S. zooepidemicus was cultured
with fresh Todd-Hewitt broth (THB) medium. E.coli was cultured
with fresh Luria–Bertani (LB) medium. S. cerevisiae was cultured
with fresh Yeast Extract Peptone Dextrose Adenine hemisulfate
(YPDA) medium.
Raw264.7 cells and HEK 293 cells were transiently transfected
using Lipofectamine 2000 and opti-MEM (Invitrogen Corp.,
Carlsbad, CA) according to the manufacturer’s instruction. Media
were changed 6 h post transfection and the cells were treated or
assayed 24 h post transfection. S. cerevisiae was transformed using
the LiAc method [34]. Lysates were subject to Western-blot
analysis to confirm the expression of the bait gene in the pDHB1
plasmid.
Split-ubiquitin yeast two-hybrid assay
We used the Split-ubiquitin yeast two-hybrid DUALhunter
system (Dualsystems Biotech, Switzerland) to identify SzP
interaction partners from the porcine macrophages [35,36]. The
coding region of S. zooepidemicus ATCC35246 SzP (GenBank
No. EU624402.1), excluding the signal sequence, was amplified by
PCR using primers 59- GCGGCACGGCCATTACGGCCGTT-
GAGTCAGCTAAGCCTGTA -39(SfiI) and 59- GCAGCGC-
GGCCGAGGCGGCCTTTTCTTTGCGTCTTGTTGAC -39
(SfiI). PCR product was then inserted into the Split-ubiquitin
yeast two-hybrid Cub domain vector pDHB1 to generate the ‘bait’
plasmid pDHB1-SzP, which was verified by DNA sequencing.
The expression of the bait protein was confirmed. pDHB1-SzP
was used to screen a porcine PAM cDNA library (constructed by
our lab) for identifying SzP interacting proteins. Positive yeast clones
containing the library plasmid encoding Szp interacting proteins
were purified and retested for their growth phenotypes. Plasmid
DNApreparationsfortheseyeastclonesweregeneratedbytheYeast
Plasmid Extraction Kit (Biomega). The insert fragment of these prey
plasmids was detected by PCR amplification using primers pPR3N-
F( 5 9- GTCGAAAATTCAAGACAAGG -39) and pPR3N -R (59-
AGCGTGACATAACTAATTAC - 39). The chosen prey plasmids
were amplified in DH5a, recovered through ampicillin selection and
identified by DNA sequencing with pPR3N-F primer. The cDNA
sequences were used to search GenBank and NCBI BLAST against
the porcine genome. After banishing duplication, the remaining
plasmidswerere-transformedintotheyeastcellscontainingpDHB1-
SzP. Liquid b-galactosidase assay was used to retest for their
interaction with SzP in the yeast again.
Co-Immunoprecipitation assay
GFP was fused at the N-terminal of SzP in the S. zooepidemicus
strain ATCC35246 using the vector pAcGFP1-C (Clontech,
TAKARA Bio, USA). ProLabel tag was fuse at the N-terminal
of 12 porcine candidate proteins using the vector pProLabel-C
(Clontech). These 12 plasmids were each co-transfected with
TRX or FH were added followed by the addition of factor D to a final volume of 125 ml. Purified components only (control+); purified complement
components without factor D (control-). The inhibition of C3 convertase was determined by C3a generation after 30 min of incubation and measured
by a C3a ELISA. The effect of dosage increase of FH and TRX on C3a generation (ng/ml) was shown here. Reduction in C3a generation was correlated
with the decreased C3 convertase activity. (Symbol * indicates that a value significantly differs from the control+ group). C: Immunoblot showing C3
components eluted from the surface of the S. zooepidemicus wild strains and the SzP knockout strains following treatment of TRX, FH or TRX and FH
in porcine plasma. The blot was developed with the affinity purified antiserum to C3. C3 components eluted from the S. zooepidemicus wild strains
and the SzP knockout strains after incubation in porcine plasma were used as the negative control. D: Flow cytometry analysis of S. zooepidemicus
surface-bound C3b, a total of 10,000 events were collected per sample and a single gate was used to exclude debris. E: Flow cytometry analysis of
gradient concentration TRX pretreated S. zooepidemicus surface-bound C3b. The antiphagocytic effectiveness of the TRX was dose-dependent until
saturation. These results were the mean6SD for n=3, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0032099.g006
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Cells were harvested after 36 h incubation and lysed with the lysis
buffer containing 20 mM Tris, 200 mM NaCl, 1 mM EDTA, 0.5
NP-40 and Protease inhibitor Cocktail (Pierce, USA) and 16PMSF
(Sigma, USA). Cell lysates were incubated 2 h with anti-GFP
monoclonal antibody (Beyotime) at 4uC. Next, 30 ml of protein G
plus/A agarose beads (Clontech) was added and incubated at 4uC
overnight. Next day, the beads were washed five times with the lysis
buffer and the activity of ProLabel was measured using the
ProLabel Detection Kit II (Clontech). pAcGFP1-p53 and pProLa-
bel-T were used as the positive control, while pAcGFP1-Lam and
pProLabel-T (Clontech) were used as the negative control.
After the initial identification of the Szp/TRX interaction, it
was again confirmed with Co-IP and western-blot. Protein G plus/
A agarose beads together with anti-mouse TRX polyclonal
antibodies (Proteintech, USA) were incubated with HEK293 cell
lysates. The samples were washed extensively in the lysis buffer.
The beads were boiled in the sample buffer, and the supernatants
were loaded onto SDS-PAGE gels. To confirm the SzP/TRX
interaction, western-blot against GFP-SzP was performed using
anti-GFP monoclonal antibodies.
Reducing/Oxidizing Reagent Treatment
Oxidization treatment for TRX was performed following a
previously publish protocol [37]. Briefly, protein G beads coated
with anti-TRX polyclonal antibodies were bound to TRX and
treated with 1 mM H2O2 in Nonidet P-40 buffer for 15 min and
then washed 6 times with the buffer prior to SzP incubation. As a
control to revert oxidation, a part of the H2O2-treated fusion
protein was incubated with buffer containing 100 mM DTT for
15 min prior to SzP incubation. After 2 h incubation, samples
were centrifuged and washed five times with Nonidet P-40 buffer.
The precipitated proteins were subjected to SDS-polyacrylamide
gel electrophoresis and detected by western-blot using anti-SzP
monoclonal antibodies [38].
Mutagenesis and TRX activity assay
We used ‘‘QuikChange II Site-directed Mutagenesis Kit’’ to
construct Cys
32 and Cys
35 to Ser (C32S/C35S) double mutations in
TRX using the TRX-pPR3-N vector as the template (Stratagene).
Primers were 59 CTCAGCCACGTGGTCTGGGCCTTCCAA-
AATGATCAAGCC 39 and 59 GGCTTGATCATTTTGGAAG-
GCCCAGACCACGTGGCTGAG 39. The mutant plasmid was
named mut-TRX-pPR3-N, and transformed into the yeast strain
containing SzP-pDHB1 plasmid to detect the interaction between
SzP and mutant TRX.
TRX activity assay was performed in 96-well plates with an end
point insulin assay [39,40]. We incubated 10 mg TRX with 100 mg/
ml or 500 mg/ml SzP at 37uC for 2 h. Samples were mixed with
3.8 ml 1.7 mM TRX reductase from rat liver (Sigma), 20 ml 1:12
mixture of solution N(40 mg/ml b-NADPH) ,solution M(210 mM
HEPES, pH 7.6, 790 mM insulin, 20 mM EDTA) and TE (50 mM
Tris-HCl, pH 7.6, 20 mM EDTA) to reach a total volume of 50 ml.
The reaction mixture without TRX reductase was used as the
control for background readings. After incubating in 37uC for
30 min, 200 ml of 1 mM 5, 59- dithiobis (nitrobenzoic acid) in 6 M
guanidine hydrochloride solution was added to stop the reaction
and the absorbance was measured at 412 nm.
Recruitment of TRX to the surface of viable S.
zooepidemicus
The flow cytometry analysis of S. zooepidemicus ATCC 35246
cultured in vitro was performed as described previously [41].
Briefly, 5610
7 CFU/mL wild strain or the SzP knockout was
incubated for 30 min at 37uC in 2 mg/mL TRX. The bacteria
cells were washed with phosphate-buffered saline (PBS; pH 7.2),
collected by centrifugation, and incubated with rabbit anti-mouse
TRX polyclonal antibodies (Proteintech, USA) for 30 min at
37uC. This was followed by incubation with FITC-conjugated
goat anti-rabbit IgG secondary antibodies (Beyotime, China).
Surface-bound TRX was fluorescently stained and analyzed by a
FACS Calibur (Becton Dickinson). Data were compared by the
analysis of variance with Tukey’s correction for multiple
comparisons and Student’s t-test. P values,0.05 were considered
significant.
Macrophage TRX knockdown and Phagocytosis assays
siRNA templates were designed using online siRNA Target Finder
(Ambion, Japan) to match 20 nonconserved nucleotide sequences
within the mouse TRX mRNA. The oligo nucleotide sequences used
to create pBAsi-mU6-TRX were iTRX-sense 59- GATCCGGCTT-
GAAGCCTCTATTACTTTCAAGAGAAGTAATAGAGGCTT-
CAAGC TTTTTTACGCGTG -39 and iTRX-antisense 59-TCGA-
CACGCGTAAAAAAGCTTGAAGCCT CTATTACTTCTCT-
TGAAAGTAATAGAGGCTTCAAGCCG -39. The oligonucleo-
tides were annealed and cloned into pBAsi-mU6 (TAKARA Bio,
Japan). The expression of TRX siRNA was regulated by the mU6
promoter. Cells were harvested 24 h and 36 h after pBAsi-mU6-
TRX transfection. The lysates were collected for western-blot analysis
and total RNA was extracted to confirm TRX knockdown using RT-
PCR analysis.
The phagocytosis assay was performed using a previously
described method with some modifications [42]. The S. zooepide-
micus wild type strain was cultured to mid-exponential phase of
growth (optical density of 0.35–0.45 at 600 nm), washed, and
resuspended in Dulbecco’s phosphate-buffered saline at
1.25610
8 CFU/ml. Bacteria cells were labeled with 5.0 mg/ml
FITC (Sigma) for 20 min at 37uC and the unbound labels were
removed by 2 washes in DPBS. Labeled S. zooepidemicus were
resuspended in DMEM and chilled on ice. The Raw264.7 cells
(10
6) or TRX knock-down cells (10
6) were combined with 10
7 S.
zooepidemicus wild type or the SzP knock-out strain in a 96-well
microtiter plate on ice. Samples were mixed gently with a pipette
and rotated at 37uC for 60 min. At the desired times, samples were
placed on ice and analyzed by flow cytometry. Samples were
analyzed to determine the total number of Raw264.7 cells with
bound/ingested bacteria and then re-analyzed immediately in the
presence of an equal volume of Trypan Blue (2 mg/ml in 0.15 M
NaCl/0.02 M citrate buffer, pH 4.4) to measure the number of
Raw264.7 cells with ingested bacteria (phagocytosis). A total of
10,000 events were collected per sample and a single gate was used
to exclude debris and free bacteria (Cell Quest Pro Software, BD
Biosciences). Phagocytosis percentage was determined by the
percentage of FITC positive Raw264.7 cells after quenching with
Trypan Blue.
FH binding assay
Binding of SzP and TRX to FH was determined using the
method previously described with some modifications [43]. SzP,
TRX and SzP/TRX complex were incubated at 37uC for 2 h
before being subjected to SDS-PAGE and electro-transferred to a
PVDF membrane. After blocking with 5% non-fat dry milk in
TBST buffer, the membrane was incubated with fresh porcine
1:200 serum dilution followed by 1:8 goat anti-human FH serum
dilution (Calbiochem, La Jolla, CA) in TBST. After washing in
TBST, the blot was developed with HRP conjugated rabbit anti-
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SuperSignalH West Pico Substrate (Pierce, USA).
C3 Convertase Measurement
C3 convertase activity was measured as previously described
with some modifications [44]. Briefly, the C3 convertase was
assembled in PBS by the addition of the following purified
complement components: 10 mg C3 (Sigma); 50 ng C3i; 2 mg
factor B (Calbiochem); and 12 ml 0.1 M MgCl2. C3i, also known
as C3(H2O), was generated by five freeze/thaw cycles of the
purified C3. Varying concentrations of TRX, SzP, and the SzP/
TRX complex were added with or without 10 mg FH, followed by
200 ng factor D (Calbiochem). The reaction mixture was
incubated at 37uC for 30 minutes. The generation of C3a was
measured by ELISA (Quidel, San Diego, CA). All experiments
included positive controls (C3, C3i, factor B, and factor D) and
negative controls (C3, C3i, and factor B).
C3 binding assay
The C3 deposition assay was performed using a previously
reported protocol with some modifications [45]. Aliquots of S.
zooepidemicus wild type and SzP-knockout strains (1.5610
8 cells in
150 ml of THB medium) were incubated with 10 mg TRX, 10 mg
FH or TRX+FH for 30 min. Fresh porcine plasma (180 ml)
incubated at 37uC was then added and mixed with shaking.
Complement deposition was stopped immediately after 30 min by
the addition of 12 ml 0.5 M EDTA (pH 8.0).
Flow cytometry analysis: The cells were spun down by
centrifugation at 13,000 g for 2 min. Cell pellets were washed
twice and resuspended in PBS. Surface-bound C3b was detected
with anti-C3 antibodies (Sigma) and FITC-labeled goat anti-rabbit
IgG (Beyotime). The binding of the antibodies was measured by
flow cytometry. A total of 10,000 events were collected per sample
and a single gate was used to exclude debris (Cell Quest Pro
Software, BD Biosciences).
Western-blot analysis: the cells were spun down and resus-
pended in 80 ml 1 M hydroxylamine in carbonate buffer (pH 9.0)
after washing with PBS-1% SDS twice. The mixture was
incubated at 37uC for 1 h with gentle shaking. After centrifuga-
tion, aliquots (25 ml) of the supernatant were subjected to SDS-
PAGE and transferred to a PVDF membrane. The membrane was
incubated with a 1:100 dilution of anti-C3 antibodies (Sigma), and
developed using HRP conjugated goat anti- rabbit IgG antibodies
(Beyotime, China). The bands were visualized by Chemilumines-
cence with SuperSignalH West Pico Substrate (Pierce, USA).
Statistical analysis
All statistics were performed using an unpaired two-tailed t-test
with a 95% confidence interval. In all experiments, error bars were
denoted using the standard deviation (6SD) of the samples in
triplicates or more.
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